Medicinal Chemistry Research
H-4, and H-5 of C6H5), 7.83–7.85 (m, 2H, H-2, and H-6 of
C6H5 on Biz), 8.12 (d, J = 8.8 Hz, 2H, H-2, and H-6 of
Bis[5-{3-(p-cyanobenzylidene)-5-phenyl-1-imidazolonyl}-3-
oxypentyloxo]tetraphenylporphyrinatophosophorus
chloride (1b)
−
C6H4OH); HRMS Calcd for C19H17N2O3 [M−H]−:
321.1245, m/z 321.1245. Found: 321.1245.
Purple solid. Yield 14%. mp > 300 °C; IR (KBr) νmax 3057,
1
Preparation of P-porphyrins (1a–1c) with
benzylidene imidazolone (Biz) units linked through
the axial ligands
2939, 2226, 1714, 1644, 1022, 803, 759, 704 cm−1; H
NMR δ = −2.30 (dt, JP–H = 12.4 Hz, J = 5.2 Hz, 4H, P-
OCH2-), 0.56–0.59 (m, 4H, P-OCH2CH2-), 2.33 (t, J = 5.4
Hz, 4H, -O CH2CH2N-), 2.91 (t, J = 5.4 Hz, 4H,
-OCH2CH2N-), 6.80 (s, 2H, -CH=C<), 6.84–6.88 (m, 4H,
H-3, and H-5 of C6H5 on Biz), 6.92–6.94 (m, 4H, H-2, and
H-6 of C6H5 on Biz), 7.37–7.41 (m, 2H, H-2 of C6H5 on
Biz), 7.69–7.78 (m, 8H, H-3, H-4, and H-5 of C6H5 at meso
position), 7.71 (d, J = 8.3 Hz, 2H, H-3, and H-5 of
C6H4CN), 7.85–7.87 (m, 8H, H-2, and H-6 of C6H5 at meso
position), 8.24 (d, J = 8.3 Hz, 2H, H-2, and H-6 of
C6H4CN), 8.94 (d, JP–H = 2.9 Hz, 8H, pyrrole β); 13C NMR:
1a was prepared by heating tetraphenylporphyrinato
(dichloro)phosphorus(V) chloride ([Cl2P(tpp)]Cl, 30 mg)
with 2a (200 mg) in a mixed solvent of MeCN (10 mL) and
pyridine (1.0 mL) at 110 °C for 5 days in a pressure bottle.
The crude product was purified via column chromatography
on silica gel to afford 1a (8.0 mg) in 14% yield. Similarly,
1b and 1c were prepared from 2b and 2c, respectively.
Bis[3-{3-(p-trifluoromethylbenzylidene)-5-phenyl-1-
imidazolonyl}propyloxo]
tetraphenylporphyrinatophosophorus chloride (1a)
δ = 40.95 (CH2, -O-CH2-CH2-N), 60.31 (CH2, d, JP–C =
15.2 Hz, P-O-CH2-CH2-), 66.60 (CH2, O-CH2-CH2-N),
66.85 (CH2, d, JP–C = 18.3 Hz, P-O-CH2CH2-), 112.88 (C,
C-4 of C6H4CN), 116.28 (C, meso of porphyrin ring),
118.63 (C, -CN), 124.92 (CH, -CH=C<), 128.10 (C, C-1 of
C6H5 on Biz), 128.32 (CH, C-2, and C-6 of C6H5 on Biz),
128.32 (CH, C-3, and C-5 of C6H5 on Biz), 128.57 (CH, C-
3, and C-5 of C6H5 at meso position), 129.84 (CH, C-4 of
C6H5 at meso position), 131.50 (CH, C-4 of C6H5 on Biz),
132.30 (CH, C-3, and C-5 of C6H4CN), 132.38 (CH, C-2,
and C-6 of C6H4CN), 133.05 (CH, d, JP–C = 5.3 Hz, pyrrole
β), 133.46 (CH, C-2, and C-6 of C6H5 at meso position),
135.14 (C, C-1 of C6H5 at meso position), 138.41 (C, C-1 of
C6H4CN), 139.08 (C, pyrrole α), 140.46 (C, C-3 of imi-
dazolone), 164.13 (C, C-5 of imidazolone), 170.78 (C, C-2
of imidazolone); HRMS Calcd for C86H64N10O6P+ [M+]:
1363.4742, m/z 1363.4742. Found: 1363.4763.
Purple solid. Yield 14%. mp > 300 °C; IR (KBr) νmax 3058,
2931, 1714, 1644, 1323, 1168, 1124, 1068, 1022, 803, 758,
702 cm−1; 1H NMR δ = −2.47 (dt, JP–H = 14.5 Hz, J = 6.5
Hz, 4H, P-OCH2-), −1.27 (t, J = 6.5 Hz, 4H, P-OCH2CH2-
), 1.84 (t, J = 6.5 Hz, 4H, P-OCH2CH2CH2-), 6.66 (s, 2H,
-CH=C<), 6.83–6.85 (m, 4H, H-2, and H-6 of C6H5 on
Biz), 7.07–7.10 (m, 4H, H-3, and H-5 of C6H5 on Biz),
7.35–7.39 (m, 2H, H-2 of C6H5 on Biz), 7.65–7.71 (m, 8H,
H-3, and H-5 of C6H5 at meso position), 7.71 (d, J = 8.3 Hz,
2H, H-3, and H-5 of C6H4CF3), 7.74–7.78 (m, 4H, H-4 of
C6H5 at meso position), 7.82–7.84 (m, 8H, H-2, and H-6 of
C6H5 at meso position), 8.19 (d, J = 8.3 Hz, 2H, H-2 and H-
6 of C6H4CF3), 8.99 (d, JP–H = 2.8 Hz, 8H, pyrrole β); 13C
NMR: δ = 26.66 (CH2, d, JP–C = 15.2 Hz, P-O-CH2-CH2-),
37.16 (CH2, P-O-CH2-CH2-CH2-), 59.03 (CH2, d, JP–C
=
Bis[5-{3-(p-cyanobenzylidene)-5-(p-cyanophenyl)-1-
imidazolonyl}-3-oxypentyloxo]
tetraphenylporphyrinatophosophorus chloride (1c)
14.1 Hz, P-O-CH2-), 116.19 (C, meso of porphyrin ring),
123.89 (C, q, JF–C = 271.8 Hz, -CF3), 125.48 (CH,
-CH=C<), 125.67 (CH, q, JF–C = 3.7 Hz, C-3, and C-5 of
C6H4CF3), 127.57 (CH, C-2, and C-6 of C6H5 on Biz),
127.71 (C, C-1 of C6H5 on Biz), 128.45 (CH, C-3, and C-5
of C6H5 at meso position), 128.59 (CH, C-3 and C-5 of
C6H5 on Biz), 129.76 (CH, C-4 of C6H5 at meso position),
131.46 (C, q, JF–C = 32.5 Hz, C-4 of C6H4CF3), 131.76
(CH, C-4 of C6H5 on Biz), 132.37 (CH, C-2, and C-6 of
C6H4CF3), 133.11 (CH, d, JP–C = 5.1 Hz, pyrrole β), 133.50
(CH, C-2, and C-6 of C6H5 at meso position), 135.09 (C, C-
1 of C6H5 at meso position), 137.32 (C, C-1 of C6H4CF3),
139.15 (C, C-3 of imidazolone), 139.23 (C, pyrrole α),
162.08 (C, C-5 of imidazolone), 169.72 (C, C-2 of imida-
zolone); 19F NMR (376 MHz): δ = −62.82; HRMS Calcd
for C84H60F6N8O4P+ [M+]: 1389.4374, m/z 1389.4374.
Found: 1389.4401.
Purple solid. Yield 3.4%. mp > 300 °C; IR (KBr) νmax 3058,
2959, 2226, 1716, 1661, 1443, 1384, 1022, 804, 759, 703
1
cm−1; H NMR δ = −2.23 (dt, JP–H = 13.3 Hz, J = 4.8 Hz,
4H, P-OCH2-), 0.63–0.66 (m, 4H, P-OCH2CH2-), 2.43 (t, J
= 4.9 Hz, 4H, -OCH2CH2N-), 2.90 (t, J = 4.9 Hz, 4H,
-OCH2CH2N-), 6.86 (s, 2H, -CH=C<), 6.89 (d, J = 8.5 Hz,
4H, H-3, and H-5 of C6H4CN on Biz), 6.98 (d, J = 8.5 Hz,
4H, H-2, and H-6 of C6H4CN on Biz), 7.70–7.79 (m, 8H,
H-3, H-4, and H-5 of C6H5 at meso position), 7.75 (d, J =
8.3 Hz, 2H, H-3, and H-5 of C6H4CN on olefin), 7.85–7.87
(m, 8H, H-2, and H-6 of C6H5 at meso position), 8.24 (d, J
= 8.3 Hz, 2H, H-2, and H-6 of C6H4CN on olefin), 8.97 (d,
JP–H = 2.9 Hz, 8H, pyrrole β); HRMS Calcd for